363 related articles for article (PubMed ID: 27916412)
1. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
Akhtar M; Qadri F; Bhuiyan TR; Akter S; Rafique TA; Khan A; Islam LN; Saha A; Svennerholm AM; Lundgren A
Vaccine; 2017 Jan; 35(2):321-328. PubMed ID: 27916412
[TBL] [Abstract][Full Text] [Related]
2. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
[TBL] [Abstract][Full Text] [Related]
5. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.
Saha A; Chowdhury MI; Nazim M; Alam MM; Ahmed T; Hossain MB; Hore SK; Sultana GN; Svennerholm AM; Qadri F
Vaccine; 2013 Jan; 31(4):647-52. PubMed ID: 23200936
[TBL] [Abstract][Full Text] [Related]
6. Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults.
Matias WR; Falkard B; Charles RC; Mayo-Smith LM; Teng JE; Xu P; Kováč P; Ryan ET; Qadri F; Franke MF; Ivers LC; Harris JB
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004753. PubMed ID: 27308825
[TBL] [Abstract][Full Text] [Related]
7. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
Dash P; Hakim A; Akter A; Banna HA; Kaisar MH; Aktar A; Jahan SR; Ferdous J; Basher SR; Kamruzzaman M; Chowdhury F; Akter A; Tauheed I; Weil AA; Charles RC; Calderwood SB; Ryan ET; LaRocque RC; Harris JB; Bhuiyan TR; Qadri F
mSphere; 2024 Mar; 9(3):e0056523. PubMed ID: 38391226
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
[TBL] [Abstract][Full Text] [Related]
9. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
[TBL] [Abstract][Full Text] [Related]
10. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
11. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
[TBL] [Abstract][Full Text] [Related]
14. A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in Humans.
Mottram L; Lundgren A; Svennerholm AM; Leach S
Front Immunol; 2021; 12():647873. PubMed ID: 33828557
[TBL] [Abstract][Full Text] [Related]
15. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.
Leung DT; Rahman MA; Mohasin M; Riyadh MA; Patel SM; Alam MM; Chowdhury F; Khan AI; Kalivoda EJ; Aktar A; Bhuiyan MS; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2011 Aug; 18(8):1317-25. PubMed ID: 21697337
[TBL] [Abstract][Full Text] [Related]
16. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.
Alam MM; Leung DT; Akhtar M; Nazim M; Akter S; Uddin T; Khanam F; Mahbuba DA; Ahmad SM; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2013 Oct; 20(10):1541-8. PubMed ID: 23925888
[TBL] [Abstract][Full Text] [Related]
17. Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial.
Mottram L; Lundgren A; Svennerholm AM; Leach S
Vaccine; 2020 Jan; 38(3):655-662. PubMed ID: 31703936
[TBL] [Abstract][Full Text] [Related]
18. Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory.
Leach S; Lundgren A; Svennerholm AM
Vaccine; 2013 Jun; 31(30):3035-8. PubMed ID: 23664997
[TBL] [Abstract][Full Text] [Related]
19. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.
Clemens JD; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; van Loon F; Khan MR; Yunis M; Huda S
Vaccine; 1990 Oct; 8(5):469-72. PubMed ID: 2251873
[TBL] [Abstract][Full Text] [Related]
20. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
